Document is current
Any future updates will be listed below
-
Authors
Lommen, Marie
Weindler, Jasmin J.
Jablonski, Janina
Rosenbrock, Johannes
Borchmann, Peter
Behringer, Karolin
Roth, Katrin S.
Ufton, Dominic
Dietlein, Markus
Kobe, Carsten
Ferdinandus, Justin https://orcid.org/0000-0002-3481-7997
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 27 June 2025
Accepted: 3 September 2025
First Online: 11 October 2025
Declarations
:
: The three trials were approved by the local ethics committees and conducted according to the Declaration of Helsinki and the Good Clinical Practice guidelines of the International Conference on Harmonization.
: Informed consent was obtained from all individual participants included in the study.
: All participants agreed to publication of aggregate data. No individual patient data is presented in this manuscript.
: JF reports honoraria from Takeda Oncology and Roche. DU reports research funding by the Collaborative Research Centre 1451 (Sonderforschungsbereich 1451). PB reports institutional grants, honoraria, and travel support from Takeda Oncology. KB reports honoraria from Takeda. All other authors declare no competing interests.
